Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex Sodium in Scleroderma
NCT02166229Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of divalproex sodium in systemic sclerosis (SSc), sponsored by Yale University. Planned start Jun 2014; status: withdrawn.
02
Drugs
divalproex sodium
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT02166229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166229.